Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 10.060\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a Cc1cc(C)nc(N/N=C/c2cccc(Cl)c2)n1
b Cc1cc(C)c(/C=C(\C#N)C(N)=S)c(C)c1
c CCC(O)(c1ccc(OC)cc1)C(CN1CCOCC1)c1ccccc1.Cl
d CC(NC(=O)c1ccc(Cl)cc1)c1nnc(SCC(=O)NC2=NCCS2)n1C
Answer: c. CCC(O)(c1ccc(OC)cc1)C(CN1CCOCC1)c1ccccc1.Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(O)(c1ccc(OC)cc1)C(CN1CCOCC1)c1ccccc1.Cl
CCC(O)(c1ccc(OC)cc1)C(CN1CCOCC1)c1ccccc1.Cl
3-(4-methoxyphenyl)-1-morpholin-4-yl-2-phenylpentan-3-ol;hydrochloride